Tech Company Financing Transactions

Kriya Therapeutics Funding Round

Kriya Therapeutics, based in Redwood City, secured $320 million in funding from Patient Square Capital, Premji Invest and private investors.

Transaction Overview

Company Name
Kriya Therapeutics
Announced On
9/11/2025
Transaction Type
Venture Equity
Amount
$320,000,000
Round
Series D
Investors

Patient Square Capital (Lead Investor) (Jim Momtazee)

Premji Invest (Lead Investor) (Akshay Rai)

private investors (Peter Thiel)

JDRF T1D Fund

Narya Capital

Proceeds Purpose
The company intends to use the funds to support clinical trials of its gene therapies in multiple therapeutic areas, as well as the continued utilization of its research and manufacturing engine for new product development

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1100 Island Dr. 203
Redwood City, CA 94065
USA
Phone
Undisclosed
Website
www.kriyatherapeutics.com
Email Address
[email protected]
Overview
The era of gene therapy has arrived. Our mission at Kriya Therapeutics is to expand the reach of gene therapy to address highly prevalent and serious diseases affecting millions of patients. Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases.
Profile
Kriya Therapeutics LinkedIn Company Profile
Social Media
Kriya Therapeutics Company Twitter Account
Company News
Kriya Therapeutics News
Facebook
Kriya Therapeutics on Facebook
YouTube
Kriya Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Roger Jeffs
  Roger Jeffs LinkedIn Profile  Roger Jeffs Twitter Account  Roger Jeffs News  Roger Jeffs on Facebook
Chief Executive Officer
Shankar Ramaswamy
  Shankar Ramaswamy LinkedIn Profile  Shankar Ramaswamy Twitter Account  Shankar Ramaswamy News  Shankar Ramaswamy on Facebook
Chief Financial Officer
Daniel Chen
  Daniel Chen LinkedIn Profile  Daniel Chen Twitter Account  Daniel Chen News  Daniel Chen on Facebook
Chief Medical Officer
Ilise Lombardo
  Ilise Lombardo LinkedIn Profile  Ilise Lombardo Twitter Account  Ilise Lombardo News  Ilise Lombardo on Facebook
Chief Technical Officer
Nachi Gupta
  Nachi Gupta LinkedIn Profile  Nachi Gupta Twitter Account  Nachi Gupta News  Nachi Gupta on Facebook
Co-Founder
Fraser Wright
  Fraser Wright LinkedIn Profile  Fraser Wright Twitter Account  Fraser Wright News  Fraser Wright on Facebook
Controller
Amy Chen
  Amy Chen LinkedIn Profile  Amy Chen Twitter Account  Amy Chen News  Amy Chen on Facebook
Vice President
Ashlyn Bassiri
  Ashlyn Bassiri LinkedIn Profile  Ashlyn Bassiri Twitter Account  Ashlyn Bassiri News  Ashlyn Bassiri on Facebook
Vice President
Erik Hughes
  Erik Hughes LinkedIn Profile  Erik Hughes Twitter Account  Erik Hughes News  Erik Hughes on Facebook
Vice President
Mitch Lower
  Mitch Lower LinkedIn Profile  Mitch Lower Twitter Account  Mitch Lower News  Mitch Lower on Facebook
Vice President
Jason Mallory
  Jason Mallory LinkedIn Profile  Jason Mallory Twitter Account  Jason Mallory News  Jason Mallory on Facebook
Vice President
Zhu Pirot
  Zhu Pirot LinkedIn Profile  Zhu Pirot Twitter Account  Zhu Pirot News  Zhu Pirot on Facebook
Vice President
Joseph Rabinowitz
  Joseph Rabinowitz LinkedIn Profile  Joseph Rabinowitz Twitter Account  Joseph Rabinowitz News  Joseph Rabinowitz on Facebook
Vice President
Stephen Soltys
  Stephen Soltys LinkedIn Profile  Stephen Soltys Twitter Account  Stephen Soltys News  Stephen Soltys on Facebook
Vice President
Michele Stone
  Michele Stone LinkedIn Profile  Michele Stone Twitter Account  Michele Stone News  Michele Stone on Facebook
Vice President
Wayne Yount
  Wayne Yount LinkedIn Profile  Wayne Yount Twitter Account  Wayne Yount News  Wayne Yount on Facebook
VP - Administration
Lily Nguyen
  Lily Nguyen LinkedIn Profile  Lily Nguyen Twitter Account  Lily Nguyen News  Lily Nguyen on Facebook
VP - Bus. Development
Melissa Rhodes
  Melissa Rhodes LinkedIn Profile  Melissa Rhodes Twitter Account  Melissa Rhodes News  Melissa Rhodes on Facebook
VP - General Counsel
Dana Johnson
  Dana Johnson LinkedIn Profile  Dana Johnson Twitter Account  Dana Johnson News  Dana Johnson on Facebook
VP - Manufacturing
Britt Petty
  Britt Petty LinkedIn Profile  Britt Petty Twitter Account  Britt Petty News  Britt Petty on Facebook
VP - Regulatory Affairs
Harold Alterson
  Harold Alterson LinkedIn Profile  Harold Alterson Twitter Account  Harold Alterson News  Harold Alterson on Facebook
VP - Regulatory Affairs
Brian Furmanski
  Brian Furmanski LinkedIn Profile  Brian Furmanski Twitter Account  Brian Furmanski News  Brian Furmanski on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/11/2025: Oneio venture capital transaction
Next: 9/11/2025: Odyssey Therapeutics venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.